A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019

A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019

The effects of cytokine inhibition in the different phases of the severe coronavirus disease 2019 (COVID-19) are currently at the center of intense debate, and preliminary results from observational studies and case reports offer conflicting results thus far. The identification of the correct timing...

Full description

Bibliographic Details
Main Authors: Ludovico De Stefano, Francesca Bobbio-Pallavicini, Antonio Manzo, Carlomaurizio Montecucco, Serena Bugatti
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
cytokine storm
coronavirus
tocilizumab (IL-6 inhibitor)
T cell
immune activation
innate and adaptive immune response
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.572635/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.572635/full

Similar Items